Micro-ultrasound for checking prostate cancer during active surveillance
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new type of ultrasound, called micro-ultrasound, to see if it can better find significant prostate cancer in men who are on active surveillance. If you qualify, this could help your doctor decide if your cancer is truly low-risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 45 to 75.
- You have prostate cancer that is either being watched (active surveillance) or you are eligible for that approach.
- Your MRI does not show suspicious areas or has been stable over time.
- A previous biopsy showed only low-risk cancer (Grade Group 1, or Grade Group 2 with a small amount of pattern 4).
- Your PSA is 15 or lower, and your PSA density is under 0.15.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This study uses special prostate MRI scans to see how prostate cancer changes over time while you stay on active surveillance. It also looks at prostate tissue to understand your cancer’s genetics, which may help guide future decisions.
This study explores using repeated MRI scans to catch prostate cancer early in men who have never had a biopsy. If you have a suspicious spot on an MRI, you might be able to get careful monitoring without immediate biopsy, which could help avoid unnecessary procedures.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This trial tests a new imaging test called rhPSMA-7.3 (18F) PET/CT to see if it can better detect prostate cancer in men who are on active surveillance because their cancer is considered low-risk or favorable intermediate-risk. You would also get an MRI and a biopsy as part of the study.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.